Oxbridge Re Holdings Ltd - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Oxbridge Re Holdings Limited (the "Company") on February 2, 2026, regarding an event reported on February 10, 2026. The Company, incorporated in the Cayman Islands, operates in the reinsurance sector. The filing discloses the commencement of a capital raising initiative by its indirect wholly-owned subsidiary, SurancePlus Inc.
Key Financial Metrics and Offering Details
The filing does not provide historical revenue, profit, cash flow, or debt metrics for the Company. Instead, it details the terms of a new securities offering:
- Instrument: Participation Shares represented by digital tokens ("T20-2027" and "T42-2027").
- Initial Volume: Up to 2,000,000 Participation Shares.
- Price: $10.00 per Participation Share, with discounts up to 5% for larger investments.
- Investment Structure: Proceeds will be used to purchase participating notes from Oxbridge Re NS, which will be invested in collateralized reinsurance contracts.
- Return Profile: Investors receive an "Investor Final Return" consisting of the initial price plus allocated net underwriting profits.
- Hurdle Rates: A preferred return hurdle of 8% (annualized) for balanced yield shares and 16% (annualized) for high yield shares. Below the hurdle, 100% of profits go to investors; above the hurdle, profits are split 80% to investors and 20% to SurancePlus.
Material Changes
The primary material change is the launch of the Participation Share Investment Contract (PSIC). This represents a new method of capital formation for the Company's reinsurance operations, distinct from traditional equity or debt offerings. The filing notes that the quantity of shares to be issued in subsequent years (2027 and 2028) will be disclosed prior to issuance.
Guidance, Risks, and Contingencies
Regulatory Status: The Securities are not registered under the Securities Act of 1933. They are being sold under exemptions (Rule 506(c) for U.S. accredited investors and Regulation S for non-U.S. persons). The filing explicitly states it does not constitute an offer to sell.
Risks and Uncertainties:
- There is no assurance that the offering will be completed.
- The filing contains forward-looking statements subject to risks and uncertainties that could cause actual results to differ materially from expectations.
- Investors are directed to the "Risk Factors" section of the Company's Form 10-K filed on March 26, 2025, for a comprehensive list of risks.
Investor Verification Checklist
- Verify the final terms and total capital raised in the Participation Share offering, as completion is not guaranteed.
- Review the Confidential Private Placement Memorandum for detailed terms, as this 8-K is not an offer document.
- Examine the Form 10-K filed on March 26, 2025, for specific risk factors related to the Company's reinsurance operations and digital token issuance.
- Confirm the specific allocation of net underwriting profits and the performance of the collateralized reinsurance contracts in future reporting periods.
- Monitor disclosures regarding the issuance of Participation Shares for the years 2027 and 2028.